Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oasmia Pharmaceutical AB (NASDAQ:OASM)

1.05
Delayed Data
As of 3:47pm ET
 +0.0179 / +1.73%
Today’s Change
0.85
Today|||52-Week Range
3.64
-61.96%
Year-to-Date
No recent news for Oasmia Pharmaceutical AB.

Today’s Trading

Previous close1.03
Today’s open1.07
Day’s range0.98 - 1.12
Volume10,800
Average volume (3 months)13,743
Market cap$178.4M
Dividend yield--
Data as of 3:47pm ET, 09/19/2017

Growth & Valuation

Earnings growth (last year)+1.82%
Earnings growth (this year)+59.03%
Earnings growth (next 5 years)--
Revenue growth (last year)-97.41%
P/E ratio--
Price/Sales4,136.78
Price/Book1.23

Competitors

 Today’s
change
Today’s
% change
TYMETyme Technologies In...-0.50-8.06%
BGNEBeiGene Ltd+2.37+2.86%
TEVATeva Pharmaceutical+0.20+1.18%
Data as of 4:00pm ET, 09/19/2017

Financials

Next reporting dateDecember 1, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$19.6K
Annual profit (last year)-$18.3M
Net profit margin-93,164.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer
Mikael Asp
Chief Financial Officer
Fredrik Gynnerstedt
Corporate headquarters
Uppsala, Uppsala

Forecasts